|
Re: Resverlogix Announces New Insights into the Mechanism of Apabetalone's Cardioprotective Benefit in Chronic Kidney Disease Patients
|
|
Resverlogix Corp.
|
Jun 14, 2023 03:46PM
|
|
Update on the 16th
|
|
Resverlogix Corp.
|
Dec 18, 2021 02:39PM
|
|
Re: Ownership Update
|
|
Resverlogix Corp.
|
Feb 27, 2023 12:19PM
|
|
CANADA INVOLVEMENT
|
|
Resverlogix Corp.
|
Aug 13, 2018 10:56AM
|
|
Re: IR response
|
|
Resverlogix Corp.
|
Jan 11, 2022 03:44PM
|
|
Re: Anyone signed up for ESC 2021?
|
|
Resverlogix Corp.
|
Aug 09, 2021 10:36AM
|
|
Re: Daily stk quots
|
|
Resverlogix Corp.
|
Oct 12, 2020 03:36PM
|
|
Re: TD Zenith Capital Corp | Grey Market : ZHCLF
|
|
Zenith Epigenetics
|
Oct 16, 2020 01:28PM
|
|
Re: MERK
|
|
Resverlogix Corp.
|
Sep 30, 2021 08:35AM
|
|
Re: Third Eye, AHA, US Listing
|
|
Resverlogix Corp.
|
Sep 19, 2019 10:37AM
|
|
Re: Downloaded presentation…
|
|
Resverlogix Corp.
|
Jun 22, 2021 03:59PM
|
|
Re: Potential Scope of Indications for Apabetalone (selective BRD/BD inhibition)
|
|
Resverlogix Corp.
|
Nov 30, 2022 12:26PM
|
|
AHA NEWS
|
|
Resverlogix Corp.
|
Sep 23, 2019 07:03PM
|
|
Re: I got a bee in my bonnet again....Disclosure
|
|
Resverlogix Corp.
|
May 26, 2018 10:25AM
|
|
Re: Snow Job
|
|
Resverlogix Corp.
|
Dec 22, 2021 11:23PM
|
|
INTERESTING EXAMPLE OF WHAT MIGHT HAPPEN
|
|
Resverlogix Corp.
|
Jul 25, 2020 12:08PM
|
|
Re: "Do we actually have a Breakthrough Therapy Designation?"
|
1
|
Resverlogix Corp.
|
Jun 14, 2023 03:44PM
|
|
Re: Resverlogix Announces New Insights into the Mechanism of Apabetalone's Cardioprotective Benefit in Chronic Kidney Disease Patients
|
1
|
Resverlogix Corp.
|
Jun 14, 2023 03:47PM
|
|
Re: My Rant - Limited attendance AGM, one way communication, vetted questions
|
1
|
Resverlogix Corp.
|
Jun 21, 2022 09:07AM
|
|
Re: Option #2
|
1
|
Resverlogix Corp.
|
Sep 11, 2020 08:24PM
|
